Icd Primary Prevention denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for icd primary prevention are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Denies a Primary-Prevention ICD as Not FDA-Approved — and Why You Can Appeal

A "not FDA-approved" denial for a primary-prevention implantable cardioverter-defibrillator (ICD) is relatively rare for a standard transvenous ICD, because devices of this type hold FDA clearance or approval for their indicated uses. This denial type is more likely to arise in specific scenarios: the requested device is a subcutaneous ICD (S-ICD) or extravascular ICD (EV-ICD) model with a more recent regulatory history, the specific indication is being treated as outside the cleared labeling, or the denial is based on a clerical or coding error by the plan. If you receive this denial, verifying the regulatory status of the specific device and indication is the immediate priority.

## Your Federal Appeal Rights

Under ACA §2719, fully-insured plan members have the right to external review by an independent review organization after exhausting internal appeals — generally within four months of the final internal denial. ERISA §503 protects self-funded plan members' right to a full-and-fair internal review followed by federal court access. Experimental and not-approved denials are subject to external review under federal rules, and independent reviewers apply current medical and regulatory evidence.

## Concrete Appeal Process

1. Obtain the denial letter specifying exactly which device, device model, or indication UHC asserts lacks FDA approval. 2. Verify the device's regulatory status using the FDA's 510(k) or PMA database (accessible at fda.gov) and obtain the relevant clearance or approval letter. 3. File Level 1 internal appeal attaching the FDA clearance documentation and your physician's letter establishing that the device and indication fall within the cleared labeling. 4. Escalate to Level 2 if upheld, then request external review.

## Documentation to Gather

• FDA clearance or approval documentation: the specific 510(k) premarket notification or PMA approval for the device model being implanted, with the cleared indications for use.
• Indication-to-clearance mapping: a letter from your electrophysiologist confirming that the proposed use falls within the device's FDA-cleared indications.
• Manufacturer's IFU (Instructions for Use): the labeled indications section of the device's official instructions, which can be obtained from the manufacturer.
• Clinical necessity records: echocardiogram, EP consultation, and cardiac history establishing the primary-prevention indication — so the appeal addresses both the regulatory and clinical dimensions.

## Criteria-Mapping Structure

| UHC Not-Approved Denial Basis (verbatim) | Regulatory and Clinical Response | |---|---| | [Paste exact denial language] | [FDA clearance number, cleared indication text, physician statement] |